Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 1c; Offers FY22 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.88 +0.05 (6.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.83 | 52 Week High | $19.41 | |||
| Open | $0.81 | 52 Week Low | $4.83 | |||
| Day High | $0.99 | P/E | N/A | |||
| Day Low | $0.78 | EPS | $-2.74 | |||
| Volume | 6,835,528 | |||||
